1-3 of 3
Eiji Suzuki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients

Eiji Suzuki, Rinpei Niwa, Shigehira Saji, Mariko Muta, Makiko Hirose, Shigeru Iida, Yukimasa Shiotsu, Mitsuo Satoh, Kenya Shitara, Masahide Kondo, Masakazu Toi
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (6): 1875–1882.
https://doi.org/10.1158/1078-0432.CCR-06-1335
Published: 15 March 2007
View article titled, A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients
Open the PDF for A Nonfucosylated Anti-HER2 Antibody Augments Antibody-Dependent Cellular Cytotoxicity in Breast Cancer Patients in another window
Journal Articles

Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity

Eiji Suzuki, Veena Kapoor, Arminder Singh Jassar, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (18): 6713–6721.
https://doi.org/10.1158/1078-0432.CCR-05-0883
Published: 15 September 2005
View article titled, Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity
Open the PDF for Gemcitabine Selectively Eliminates Splenic Gr-1<sup>+</sup>/CD11b<sup>+</sup> Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity in another window
Journal Articles

Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity

Eiji Suzuki, Veena Kapoor, H.-Kam Cheung, Leona E. Ling, Peter A. DeLong, Larry R. Kaiser, Steven M. Albelda
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (17): 5907–5918.
https://doi.org/10.1158/1078-0432.CCR-03-0611
Published: 08 September 2004
View article titled, Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity
Open the PDF for Soluble Type II Transforming Growth Factor-β Receptor Inhibits Established Murine Malignant Mesothelioma Tumor Growth by Augmenting Host Antitumor Immunity in another window